¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fast time constant circuit"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • acquisition time
    ȹµæ½Ã°£
  • activated coagulation time
    Ȱ¼ºÇ÷¾×ÀÀ°í½Ã°£
  • activated partial thromboplastin time
    Ȱ¼ºÈ­ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • bleeding time
    ÃâÇ÷½Ã°£
  • bleeding time test
    ÃâÇ÷½Ã°£°Ë»ç
  • breath holding time
    ¼ûÂü´Â½Ã°£, È£ÈíÁßÁö½Ã°£
  • circulation time
    ¼øÈ¯½Ã°£
  • clot retraction time
    ÇǶ±µÞ´ç±è½Ã°£, Ç÷º´¼öÃà½Ã°£
  • clotting time
    ÀÀ°í½Ã°£
  • coagulation time
    ÀÀ°í½Ã°£
  • colonic transit time
    ´ëÀåÅë°ú½Ã°£
  • concentration-time curve
    Ç÷Áß³óµµ°î¼±
  • conduction time
    Àüµµ½Ã°£
  • dead time
    ºÒÀÀ½Ã°£
  • diastolic filling time
    È®Àå±âÃæ¸¸½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • structural constant
    ±¸Á¶»ó¼ö
  • universal constant
    º¸Æí»ó¼ö
  • universal gravitation constant
    ¸¸À¯Àη»ó¼ö
  • velocity constant
    ¼Óµµ»ó¼ö
  • acquisition time
    ȹµæ½Ã°£
  • activated coagulation time
    Ȱ¼ºÇ÷¾×ÀÀ°í½Ã°£
  • activated partial thromboplastin time
    Ȱ¼ºÈ­ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • arm-to-retina circulation time
    ÆÈ¸Á¸·¼øÈ¯½Ã°£
  • atrioventricular conduction time
    ¹æ½ÇÀüµµ½Ã°£
  • real time acquisition
    ½Ç½Ã°£È¹µæ
  • bleeding time
    ÃâÇ÷½Ã°£
  • bleeding time test
    ÃâÇ÷½Ã°£°Ë»ç
  • breath holding time
    ¼ûÂü´Â½Ã°£
  • lead-time bias
    Á¶±â¹ß°ß±â°£¹ÙÀ̾
  • clot retraction time
    Ç÷º´ÅðÃà½Ã°£, Çǵ¢À̵ڴç±è½Ã°£
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • inertia time
    Ÿ¼º½Ã°£(öçàõãÁÊà)
  • influx time
    À¯ÀԽð£(êüìýãÁÊà).
  • inspiratory pause time
    Èí±âÈÄÈÞÁö½Ã°£.
  • inspiratory phase time
    Èí±â»ó½Ã°£.
  • inspiratory triggering response time
    Èí±âÀ¯¹ß¹ÝÀÀ½Ã°£.
  • persistence time
    Áö¼Ó½Ã°£(ò¥áÙãÁÊà).
  • phonation time
    ¹ß¼ºÁö¼Ó½Ã°£
  • plasma prothrombin time
    Ç÷ÀåÇÁ·ÎÆ®·Òºó ½Ã°£.
  • polymerizing time
    ±»´Â ½Ã°£ (ÁßÇÕ ½Ã°£)
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£.
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó ½Ã°£
  • prothromhin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£(¡­ãÁÊà).
  • reaction time
    ¹ÝÀÀ½Ã(°£)(ÚãëëãÁÊà).
  • real time
    ½Ç½Ã°£, Áï½Ã.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • constant temperature bath
    Ç׿¿å
  • constant velocity
    °íÁ¤ ¼Óµµ
  • corpuscular constant
    ÀûÇ÷±¸»ó¼ö(ËøÌ´Ë´ Ë×?).
  • decay constant
    ºØ±«»ó¼ö
  • dielectric constant
    À¯ÀüÀ²(ë¯ï³ëÒ), À¯Àü»ó¼ö, ÅõÀü»ó¼ö.
  • diffusion constant
    È®»ê»ó¼ö(¡­ßÈâ¦).
  • dissociation constant
    ÇØ¸®Á¤¼ö(ú°ìÆïÒâ¦).
  • elastic constant
    ź¼º(÷¥àõ)»ó¼ö(ßÈâ¦).
  • electrolytic dissociation constant
    Àü¸®»ó¼ö(¡­ßÈâ¦), ÀüÇØÁúÇØ¸®»ó¼ö.
  • equilibrium constant
    ÆòÇü»ó¼ö(¡­ßÈâ¦).
  • exposure rate constant
    ÇÇÆøÀ²»ó¼ö
  • filtration constant
    ¿©°ú»ó¼ö(¡­ßÈâ¦).
  • gas constant
    ±âü»ó¼ö(¡­ßÈâ¦).
  • growth constant
    ¼ºÀå»ó¼ö(ÊÙË×Ëà).
  • growth constant
    ¼ºÀå»ó¼ö(¡­ßÈâ¦).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Planck's constant
    ÇöûÅ© »ó¼ö(ßÈâ¦)
  • Rohrschneider constant
    ·Î½¬³ªÀÌ´õ »ó¼ö(ßÈâ¦)
  • salting-out constant
    ¿°¼® »ó¼ö(ç¤à°ßÈâ¦)
  • specificity constant
    ƯÀ̼º »ó¼ö(÷åì¶àõßÈâ¦)
  • specific rate constant
    ƯÀÌ ¼Óµµ»ó¼ö(÷åì¶áÜÓøßÈâ¦)
  • stabilty constant
    ¾ÈÁ¤µµ »ó¼ö(äÌïÒÓøßÈâ¦)
  • substrate constant
    ±âÁú»ó¼ö (ÐñòõßÈâ¦)
  • velocity constant
    ¼Óµµ(áÜÓø) »ó¼ö(ßÈâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • time gain control
    ½Ã°£°ÔÀÎÁ¶Àý
  • time interval
    ½Ã°£°£°Ý
  • time motion curve
    ½Ã°£¿îµ¿°î¼±
  • time of flight [=TOF]
    È帧½Ã°£, À¯Ã¼¼Óµµ°­Á¶
  • time of flight MR angiography
    À¯Ã¼¼Óµµ°­Á¶ ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ¼ú
  • time of flight phenomenon
    À¯Ã¼¼Óµµ°­Á¶Çö»ó
  • time sharing
    ½Ã°£°øÀ¯, ½ÃºÐÇÒ
  • time velocity integral
    ½Ã°£¼ÓµµÁ¤¼ö
  • TM scan(Time motion)
    ½Ã°£¿îµ¿¹æ½Ä
  • TOF [=time of flight]
    È帧½Ã°£, TOF, À¯Ã¼ ¼Óµµ °­Á¶
  • transit time
    ÀüÀ̽ð£
  • transverse relaxation time
    ȾÃàÀ̿Ͻð£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
AFB acid-fast bacillus; aflatoxin B; air fluidized bed; aortofemoral bypass
CFR case-fatality ratio; citrovorum-factor rescue; Code of Federal Regulations; complement-fixation reac...
FAB fast atom bombardment; formalin ammonium bromide; fragment, antigen-binding [of immunoglobulins]; Fr...
FAST flow-assisted, short-term [balloon catheter]; fluorescent antibody staining technique; fluoro-allerg...
FC fasciculus cuneatus; fast component [of a neuron]; febrile convulsions; feline conjunctivitis; ferri...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
Isc increase short circuit current
Isc increase the short circuit current
IC50 inhibition constant
LC lumped constant
OCP open circuit potential
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • setting time
    °æÈ­ ½Ã°£, ÀÀ°í ½Ã°£, ±»´Â ½Ã°£
    1. ºñÄÏ Ä§À» »ç¿ëÇÏ¿© ¿¬È­ °³½Ã¿¡¼­ ħÀÔ±íÀ̰¡ 1§® ÀÌÇϰ¡ µÉ ¶§±îÁöÀÇ ½Ã°£À» °æÈ­ ½Ã°£À̶ó ÇÑ´Ù. ¾ö¹ÐÈ÷ Ãʱ⠰æÈ­ ½Ã°£ÀÌ´Ù. 2. È¥ÇÕ ½ÃÀÛºÎÅÍ Àç·á°¡ ÃæºÐÇÏ¿© ÀÓ»óÀûÀ¸·Î À¯ÀǼºÀÌ ÀÖ´Â ¿µ±¸ º¯Çü ¾øÀÌ ÀλóÀ» ±¸°­ ³»¿¡¼­ Á¦°ÅÇÒ ¼ö Àִµ¥ ¼Ò¿äµÇ´Â ÃÖ¼ÒÇÑÀÇ ½Ã°£.
  • T2 relaxation time
    T2 ÀÌ¿Ï ½Ã°£
  • T2 spin spin relaxation time
    T2 ½ºÇÉ ½ºÇÉ ÀÌ¿Ï ½Ã°£
  • thermal camera time response
    ¿­ Ä«¸Þ¶ó ½Ã°£ ¹ÝÀÀ
  • time
    ½Ã°£, ¶§
    ¾î¶² ½Ã°¢°ú ½Ã°¢ÀÇ »çÀÌ.
  • time cycled ventilator
    ½Ã°£ ÁÖ±â È£Èí±â
  • time difference
    ½ÃÂ÷
  • time gain compensation
    ½Ã°£ °ÔÀÎ º¸»ó
  • time gain control
    ½Ã°£ °ÔÀÎ Á¶Àý
  • time lag
    Áöü ½Ã°£
  • time of death
    »ç¸Á ½Ã°¢
  • time of flight
    È帧 ½Ã°£, À¯Ã¼ ¼Óµµ °­Á¶
  • time of flight phenomenon
    À¯Ã¼ ¼Óµµ °­Á¶ Çö»ó
  • time sharing
    ½Ã°£ °øÀ¯, ½ÃºÐÇÒ
  • time weighted average concentration
    ½Ã°£ °¡Áß Æò±Õ ³óµµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
blood circulation time Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points.
(12 Dec 1998)
P-A conduction time See: atrioventricular conduction.
(05 Mar 2000)
generation time <cell biology> Time taken for a cell population to double in numbers and thus equivalent to the average length of the cell cycle.
(18 Nov 1997)
reaction time The time from the onset of a stimulus until the organism responds.
(12 Dec 1998)
real-time ultrasonography Rapid serial ultrasound images produced using a phased array or scanning transducer; produces a video display of organ motion, such as heart valve or foetal motion.
(05 Mar 2000)
recognition time The interval between the application of a stimulus and the recognition of its nature.
(05 Mar 2000)
partial thromboplastin time Test of the intrinsic (factors viii, ix, xi, and xii) and common (fibrinogen, prothrombin, factors v and x) pathways of coagulation in which a mixture of plasma and phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides) is recalcified and the time required for the appearance of fibrin strands measured. Activation may be provided by contact with the glass tube or exposure to activators (e.g., ellagic acid, particulate silicates such as diatomaceous earth or kaolin) before addition of the calcium chloride. It is used as a screening test and to monitor heparin therapy.
(12 Dec 1998)
relaxation time Time taken for a system to return to the resting or ground state or a new equilibrium state following perturbation. Often used in context of receptor systems that have a refractory period after responding and then relax to a competent state. Can be used more precisely to mean the time for a system to change from its original equilibrium value to 1/e of this original value.
(18 Nov 1997)
median time to elimination <pharmacology> The time it takes one half of a drug to be eliminated from the body.
(09 Oct 1997)
repetition time In magnetic resonance imaging, the time between repetitions of the pulse sequence.
(05 Mar 2000)
rise time The time required for a pulse or echo to rise from 10% to 90% of its peak amplitude.
(05 Mar 2000)
P-H conduction time See: atrioventricular conduction.
(05 Mar 2000)
running time The time during which an activity (e.g., chromatography development) occurs.
(05 Mar 2000)
Russell's viper venom clotting time A clotting time determination performed on citrated platelet-poor plasma using Russell's viper venom as an activating agent. This allows activation of factor X directly without the need for other coagulation factors and is used to confirm factor X defects.
See: Stypven time test.
(05 Mar 2000)
circulation time The time taken for the blood to pass through a given circuit of the vascular system, e.g., the pulmonary or systemic circulation, from one arm to another, from arm to tongue, or from arm to lung; it is measured by the injection into an arm vein of a substance, such as sodium dehydrocholate, ether, fluorescein, histamine, or a radium salt, which can be detected when it arrives at another point in the vascular system.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • access time
    È£Ãâ½Ã°£(±â¾ï ÀåÄ¡¿¡ Á¤º¸¸¦ ±â·Ï,ÇØµ¶ÄÉ Çϱâ À§ÇÑ ½Ã°£);ÄÄÇ»ÅÍ¿ë¾î
  • apparent time
    (ÇØ½Ã°èµîÀÇ)žçÀÇ À§Ä¡·Î ÃøÁ¤Çϴ½ð£
  • atomic time clock
    ¿øÀÚ ¿¬´ë ½Ã°è
  • atonic time clock
    ¿øÀÚ¿¬´ë
  • bad time
    °ï°æ
  • church time
    ¿¹¹è ½Ã°£
  • close time
    =CLOSE SEASON
  • closing time
    ÆóÁ¡(Á¾¾÷)½Ã°£
  • common time
    º¸ÅëÀÇ ¹ÚÀÚ(ƯÈ÷ 4ºÐÀÇ 4¹ÚÀÚ)
  • cooling time
    =COOLING-OFF PERIOD
  • coordinated universal time
    ÇùÁ¤ ¼¼°è½Ã(UTC)
  • core time
    ÄÚ¾î ŸÀÓ;Çٽð£(ÀÚÀ¯±Ù¹«½Ã°£(flextime)¿¡¼­ ¹Ýµå½Ã ±Ù¹«ÇØ¾ß ÇÏ´Â ½Å°£´ë)
  • cycle time
    »çÀÌŬ ŸÀÓ(±â¾ï ÀåÄ¡ÀÇ Àд ¼Óµµ)
  • dead time
    (ÀüÀÚ)ºÎµ¿½Ã°£;ºÒ°¨ ½Ã°£(Áö·ÉÈÄ ÀÛµ¿Çϱâ±îÁöÀÇ)
  • delayed time system
    (ÀüÀÚ)½Ã°£ Áö¿¬(ÃàÀû)¹æ½Ä
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á